Lilly Falls on Oral Obesity Pill as FDA Decision Looms
Eli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
A concise primer on initial crypto choices, risk awareness, and how to approach your first investment with clarity.
19,592 articlesEli Lilly stock fell about 5% as investors awaited the FDA's April decision on orforglipron. Novo Nordisk's intensifi...
Arizona robotics builder FrameTec is expanding its automated framing operation to slash build-cycle times and reduce ...
Macy’s stock surged after the retailer posted a third straight quarter of rising comparable sales, surpassing expecta...
A high-stakes Senate hearing over Iran policy put the spotlight on intelligence briefings and political risk. The key...
A new deduction for interest on auto loans for 2025 buyers could cut tax bills even for standard-deduction filers. Bu...
Explore how Solo Brands (SBDS) 2025 could unfold, with a clear view of revenue drivers, margins, and strategic bets. ...
A multibillion-dollar air defense push in Greece is drawing investor attention to Lockheed Martin and other defense c...
Three global e-commerce leaders are trading at bargain prices as reinvestment cycles press on near‑term earnings, pot...
Intel and AMD slid on Friday as AI competition intensifies and supply-chain tensions weigh on the sector, despite str...
Forecasts point to a higher 2027 social security cola as energy prices climb, potentially boosting benefits but signa...
In March 2026, Anduril landed a long-term Army contract valued up to $20 billion, moving defense tech from pilots to ...
Balance Homes unveils a refreshed co-ownership program featuring fee rebates, HUD-certified counseling, and ongoing c...